39 studies found for:    " June 18, 2008":" July 18, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" June 18, 2008":" July 18, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (39 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Terminated Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)
Condition: HIV Infection
Interventions: Drug: Elvitegravir;   Drug: Raltegravir;   Drug: Placebo to match elvitegravir;   Drug: Placebo to match raltegravir;   Drug: Background regimen
2 Unknown  Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)
Condition: HIV Infection
Interventions: Drug: elvitegravir;   Drug: Raltegravir
3 Completed Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics
Condition: HIV Infections
Intervention:
4 Completed Cohort Study of HIV-1 Incidence Among Clients of the Thai Red Cross AIDS Research Center, Bangkok, Thailand
Condition: HIV Infections
Intervention:
5 Completed The Human Immunodeficiency Virus and Osteopathic Manipulation Evaluation Study
Condition: HIV Infections
Intervention: Procedure: Osteopathic Manipulative Treatments
6 Completed Response to Standard HIV Treatment in Bamako, Mali
Condition: HIV Infections
Intervention:
7 Active, not recruiting Effectiveness of Antiretroviral Therapy During Acute HIV Infection
Condition: HIV Infections
Interventions: Drug: Highly Active Antiretroviral Therapy (HAART);   Other: No treatment
8 Completed
Has Results
Single DermaVir Immunization in HIV-1 Infected Patients on HAART
Condition: HIV Infection
Interventions: Biological: DermaVir;   Drug: HAART
9 Active, not recruiting Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients
Condition: HIV Infection
Interventions: Biological: DermaVir;   Biological: Placebo
10 Completed Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy
Condition: HIV Infections
Intervention: Drug: Addition of raltegravir 800 mg QD to HAART
11 Completed Healthy Activities for Prize Incentives
Conditions: Substance Abuse;   HIV Infections
Intervention: Behavioral: contingency management
12 Completed Effectiveness of a Community-level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-risk Populations
Conditions: HIV Infections;   Sexually Transmitted Diseases
Interventions: Behavioral: Community Popular Opinion Leader (C-POL);   Behavioral: HIV/STD educational materials
13 Completed Durability of Nevirapine-Based Antiretroviral Regimen
Condition: HIV Infections
Intervention: Drug: nevirapine
14 Completed Effectiveness of an HIV Prevention Program That Targets the Inner Workings of High-risk Social Networks
Condition: HIV Infections
Interventions: Behavioral: Network leader training;   Behavioral: Standard HIV risk-reduction counseling
15 Completed Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection
Condition: HIV Infections
Intervention: Drug: VRC-HIVADV014-00-VP
16 Completed VENICE Study Nevirapine Full Dose/Dose Escalation
Condition: HIV Infections
Intervention: Drug: nevirapine
17 Completed Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Emtricitabine/tenofovir disoproxil fumarate placebo;   Drug: Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate placebo;   Drug: Tenofovir 1% vaginal gel;   Drug: Tenofovir placebo
18 Unknown  Establishing Normal Values for Neuropsychological Testing in HIV-negative Thais
Condition: HIV Infections
Intervention:
19 Completed
Has Results
Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function
Condition: Human Immunodeficiency Virus (HIV) Infection
Interventions: Drug: Maraviroc;   Drug: Ritonavir;   Drug: Saquinavir
20 Completed Impact of an HPV Vaccine in HIV-Infected Young Women
Condition: HIV Infection
Intervention: Biological: HPV vaccine for strains -6, -11, -16, and -18

Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results
Indicates status has not been verified in more than two years